“…A reduction in the volume of the ICC or damage to their process has been reported in almost every clinical motility disorder that has been investigated, including Hirschsprung's disease (89,90,173), chronic constipation (198), slow-transit constipation (7,67,189), megacolon (189), gastroparesis (199), diabetic mellitus (108), inflammatory bowel disease, animal models of inflammation (102,122,127), pyloric stenosis (92,172,195), achalasia (56,61,63), and chronic idiopathic intestinal obstruction (81,156). However, there are little or no data to correlate the abnormalities of specific subtypes of ICC with specific features of motility dysfunction or clinical symptoms.…”